Publication | Closed Access

Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study

HepatologyAdditional Holmium-166 RadioembolisationMedicineRadionuclide TherapyLiver PhysiologyHepatobiliary TumorPathologyHepar PlusRadiopharmaceutical TherapyLiver CancerOncologyRadiation OncologyNuclear MedicineCancer ResearchRadiologyHealth Sciences